Keto amphetamine toxicity-focus on the redox reactivity of the cathinone designer drug mephedrone

Toxicol Sci. 2014 Sep;141(1):120-31. doi: 10.1093/toxsci/kfu108. Epub 2014 Jun 9.

Abstract

The β-keto amphetamine (cathinone, β-KA) designer drugs such as mephedrone (4-methylmethcathinone, 4-MMC) show a large degree of structural similarity to amphetamines like methamphetamine (METH). However, little is currently known about whether these substances also share the potential neurotoxic properties of their non-keto amphetamine counterparts, or what mechanisms could be involved. Here, we evaluate the cytotoxicity of β-KAs in SH-SY5Y cells using lactate dehydrogenase (LDH) assays, assess the redox potential of a range of β-KAs and non-keto amphetamines using the sensitive redox indicator 2-(4-Iodophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium (WST-1), and explore the effect of 4-MMC on the formation of protein adducts using ultra-high performance liquid chromatography/high-resolution time-of-flight mass spectrometry (UHPLC-HR-TOFMS) and on the mitochondrial respiratory chain using high-resolution respirometry. We show that treatment with β-KAs increases LDH release. Further, we demonstrate that even under physiological pH, β-KAs are effective and selective-as compared with their non-keto analogues-reductants in the presence of electron acceptors. Increased pH (range 7.6-8.0) greatly enhanced the reactivity up to sixfold. We found no evidence of protein adduct formation, suggesting the reactivity is due to direct electron transfer by the β-KAs. Finally, we show that 4-MMC and METH produce dissimilar effects on the respiratory chain. Our results indicate that β-KAs such as 4-MMC possess cytotoxic properties in vitro. Furthermore, in the presence of an electron-accepting redox partner, the ketone moiety of β-KAs is vital for pH-dependent redox reactivity. Further work is needed to establish the importance of β-KA redox properties and its potential toxicological importance in vivo.

Keywords: cathinones; mephedrone; methamphetamine; neurotoxicity; protein adducts; reducing agent; respiratory chain; β-keto amphetamine.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alkaloids / chemistry*
  • Amino Acids / chemistry
  • Animals
  • Brain / drug effects
  • Brain / metabolism
  • Cell Line, Tumor
  • Cell Proliferation / drug effects
  • Cell Survival / drug effects
  • Designer Drugs / chemistry
  • Designer Drugs / toxicity*
  • Dose-Response Relationship, Drug
  • Humans
  • Male
  • Methamphetamine / analogs & derivatives*
  • Methamphetamine / chemistry
  • Methamphetamine / toxicity
  • Mice, Inbred C57BL
  • Mitochondria / drug effects
  • Mitochondria / metabolism
  • Molecular Structure
  • Oxidation-Reduction
  • Oxygen Consumption / drug effects
  • Smegmamorpha
  • Tetrazolium Salts / chemistry

Substances

  • 2-(4-iodophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium
  • Alkaloids
  • Amino Acids
  • Designer Drugs
  • Tetrazolium Salts
  • Methamphetamine
  • cathinone
  • mephedrone